Leading the Way in Heart Health and Recovery
Is primarily indicated for patients with severe aortic stenosis (AS) who are considered high-risk or inoperable for traditional surgical aortic valve replacement (SAVR). However, with advancements in technology and experience, TAVI is increasingly being used in intermediate- and low-risk patients as well. The decision to perform TAVI is based on both clinical indications and risk stratification to ensure the best outcomes for the patient.
Book an Appointment
Low-Cost TAVI Flagship Programme
Aim
To provide affordable, high-quality Transcatheter Aortic Valve Implantation (TAVI) for patients with aortic stenosis, particularly those who are high-risk for conventional surgery, while ensuring accessibility, clinical excellence, and financial sustainability.
Objectives
1. Increase Accessibility:
○ Provide affordable TAVI treatment to patients from lower-income groups who may not afford conventional surgery.
○ Providing Tavi procedure at a very low cost to be accessible to all segments of people.
2. Deliver High-Quality Care:
○ Ensure that TAVI procedures are performed with the highest safety and efficacy standards, utilising advanced technology and skilled medical personnel.
○Follow evidence-based clinical protocols to minimize complications and improve patient outcomes.
3. Promote Early Diagnosis:
○Increase awareness and screening for aortic stenosis in underserved communities to facilitate early diagnosis and intervention.
○ Conduct community-based health camps and free check-ups to identify high-risk patients.
4. Leverage Technology:
○ Use AI and advanced imaging techniques for better pre-operative planning, patient monitoring, and post-operative care to improve outcomes and reduce costs.
○ Implement telemedicine services to provide remote consultations and follow-ups.
5. Train Healthcare Professionals:
○ Develop a comprehensive training program for doctors, nurses, and technicians to build expertise in performing TAVI at lower costs without compromising quality.
○ Encourage continuous medical education and hands-on training through fellowships and workshops.
6. Financial Sustainability:
○ Secure bulk purchasing agreements for TAVI devices and equipment to keep procedural costs low.
○ Develop partnerships with medical device companies to access low-cost, high-quality implants and negotiate volume-based discounts.
7. Monitor and Improve Outcomes:
○ Collect and analyse patient data to improve procedural techniques, reduce recovery times, and minimize readmission rates.
○ Establish a long-term patient registry to track outcomes and improve clinical decision-making for future interventions.
VISION AND MISSION OF TAVI
Vision
To revolutionise heart valve care by making minimally invasive, life-saving treatments like TAVI accessible and affordable for every patient, regardless of their economic background, ensuring better quality of life and prolonged survival through cutting-edge technology and compassionate care.
Mission
1. Deliver Excellence in Cardiovascular Care: To provide world-class TAVI procedures at an affordable cost, adhering to the highest standards of safety and quality, ensuring that even those in underserved regions have access to advanced heart treatments.
2. Empower Patients and Communities: To raise awareness about aortic stenosis and empower patients with knowledge and access to early diagnosis and treatment options through outreach programs and community health camps.
3. Promote Innovation and Education: To continually adopt the latest advancements in cardiology and medical technology, while fostering a learning environment for healthcare professionals, ensuring the sustainability and growth of TAVI expertise.
4. Drive Healthcare Equity: To bridge the gap in healthcare access by offering affordable, high-quality cardiovascular care, aiming to reduce the financial burden on patients and families while achieving equitable health outcomes.
Benefits of TAVI
- Less Invasive, Shorter Hospital Stay and Faster Recovery.
- Lower risk for high surgical risk patients.
- Lower Incidence of complications.
- Preservation of Chest anatomy.
- Reduced Need for General Anesthesia.
Book an Appointment
INDICATION OF TAVI
Aortic Stenosis (AS)
Severe symptomatic aortic stenosis in patients who are either at high risk for
conventional surgery or considered inoperable.
Symptoms: Dyspnea (shortness of breath), angina (chest pain), syncope
(fainting), heart failure.
Echocardiographic criteria:
1. Aortic valve area (AVA) < 1.0 cm².
2. Mean transvalvular gradient > 40 mmHg.
3. Peak aortic jet velocity > 4 m/s.
4. Left ventricular ejection fraction (LVEF) may be reduced due to severe AS.
Other Indications
- Bicuspid aortic valve: In certain high-risk patients with calcific bicuspid valves.
- Degenerative aortic bioprosthesis (valve-in-valve TAVI): In patients with a failing surgical bioprosthetic valve.
- Poor surgical candidates: Frail patients or those with significant comorbidities, where the risk of open-heart surgery is too high.
CONTRAINDICATIONS OF TAVI
Not every patient is suitable for TAVI. Some contraindications include:
● Inadequate access vessels: Vascular access issues (e.g., small, tortuous, or calcified femoral arteries).
● Aortic root dimensions: Extremely small or large aortic annuli that cannot accommodate available TAVI devices.
● Active endocarditis: Active infection in the heart valves is a contraindication.
● Severe aortic or mitral regurgitation: TAVI is typically designed for stenotic valves, not severely regurgitant valves.
Summary Of TAVI Risk Groups
● High-Risk/Inoperable: TAVI is the standard of care.
● Intermediate-Risk: TAVI and SAVE both show good outcomes, with TAVI being a less invasive alternative.
● Low-Risk: TAVI is becoming more common, especially for elderly patients and those favouring quicker recovery.
This comprehensive risk stratification ensures that TAVI is tailored to individual patients for optimal outcomes.
Expert Team Behind the Low-Cost TAVI Flagship Program
The expert team of cardiologists and structural heart intervention specialists behind the low-cost TAVI Flagship Program is a highly dedicated and skilled group of medical professionals committed to delivering world-class, minimally invasive heart valve procedures at an affordable cost. Their primary focus is to address the growing need for life-saving heart interventions, particularly Transcatheter Aortic Valve Implantation (TAVI), for patients suffering from aortic stenosis, especially those who are high-risk for open-heart surgery.
1. Cardiologists with Specialised Expertise in TAVI:
Our cardiologists have advanced training and extensive experience in TAVI. They’ve trained at prestigious international medical centers, ensuring exceptional patient outcomes.
2. Structural Heart Specialists:
Our structural heart specialists use cutting-edge imaging technologies for accurate diagnostics and tailored treatments.
3. Multidisciplinary Approach:
Our team collaborates with cardiac surgeons, anesthesiologists, radiologists, and nurses for comprehensive care.
4. Focus on Continuous Education and Training:
We stay updated on the latest TAVI advancements through conferences, workshops, and training programs.
5. Commitment to Affordability and Accessibility:
We partner with healthcare organizations and manufacturers to reduce costs and make TAVI accessible to all.
Terms & Conditions
The Low-Cost TAVI Flagship Program aims to provide affordable Transcatheter Aortic Valve Implantation (TAVI) for patients with aortic stenosis. These terms and conditions outline the eligibility, responsibilities, and other critical guidelines for participants. Read More…
© Copyright 2024. All Rights Reserved.
Powered by
